Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
Patients taking blood thinners (such as aspirin or warfarin), those with lower platelet counts, or individuals with bleeding disorders experience more pronounced bruising
Read safety information Supporting research A selection of peer-reviewed work on AOD 9604/MOTS-C
Smaller meals eaten more slowly ask less of a stomach that is already emptying slowly
SO WHAT IS IT
US$ 21.34
US$ 26.83
US$ 20.74
